Communiqués Amarantus BioScience Holdings, Inc.

Actions

AMBS

US02300U2050

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 21:07:54 01/10/2026			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00%		0,00%	-

Communiqués

18/11/21	Amarantus BioScience : Notification of Late Filing	PU
28/07/20	Amarantus BioScience : Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus	AQ
17/03/20	Amarantus BioScience : Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel	AQ
06/02/20	Amarantus BioScience : Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International	AQ
04/02/20	Amarantus Releases Letter to Shareholders	GL
30/01/20	Amarantus Acquires Majority Interest in CBD Wellness Company Hempori	GL
09/12/19	Amarantus to Present at 12th Annual LD Micro Main Event	GL
04/12/19	Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease	GL
21/11/19	Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics	GL
18/11/19	Amarantus Provides Recapitalization Update to Shareholders	GL
24/10/19	Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products	GL
01/12/17	Amarantus Bioscience : Provides Comprehensive Corporate Update	PR
17/11/17	Amarantus Bioscience : Enters Into Forbearance and Capital Restructuring Agreements With Holders of Secured Debt, Convertible Preferred Stock and Warrants	PR
05/04/17	Amarantus Bioscience : Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.	PR
03/06/16	Amarantus Bioscience : Completes Sale of Diagnostics Division, Announces Fiscal Year 2015 and First Quarter 2016 Financial Results	PR
21/04/16	Amarantus Bioscience : Announces Capital Infusion	PR
22/03/16	Amarantus Bioscience : Announces Cancellation of Special Meeting of Shareholders	PR
07/03/16	Amarantus Bioscience : Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health	PR
07/03/16	Amarantus Bioscience : Diagnostics and Avant Diagnostics to Form 3-Way Business Combination with Theranostics Health	PR
20/02/16	Amarantus Bioscience : Announces $3M Capital Infusion	PR
27/01/16	Amarantus Bioscience : Announces $1M Investment	PR
19/01/16	Amarantus Bioscience : Enters Into Letter of Intent to Merge Diagnostics Business Unit Into Avant Diagnostics	PR
08/12/15	Amarantus Bioscience : Announces Positive Phase 2 Data for Eltoprazine in Alzheimer's Aggression	PR